[Progress in reperfusion after acute myocardial infarction. The situation in Latin America].
Reperfusion therapy for acute myocardial infarction has dramatically reduced mortality. Coronary angioplasty and thrombolysis are the most effective reperfusion techniques. The controversy about which of the two methods is best has been superseded by a search for the most rapid and effective way of inducing reperfusion, given the overriding importance of time for saving myocardial tissue. Consequently, pharmaco-invasive strategies, prehospital thrombolysis and rapid patient transport systems have all been implemented. Typically, a certain percentage of patients do not undergo reperfusion for a range of reasons, one of the most important being treatment delay. Trends in Latin America are similar to those in other parts of the world: there is an increasing use of angioplasty instead of thrombolysis and a significant number of patients do not undergo reperfusion. Some patient registries indicate that hospital mortality tends to be higher than in Europe or the United States. There are numerous reasons for the difference, among which are a delay in presentation and a lack of access to properly equipped hospitals because of social inequality. Scientific societies have a key role to play in promoting awareness about the importance of early diagnosis and treatment throughout the health-care community, health authorities, and society in general.